Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detailHypertension and pregnancy
Foidart, Jean-Michel ULg; Rorive, Georges ULg

in Acta Cardiologica (1977), 32

Detailed reference viewed: 3 (0 ULg)
Peer Reviewed
See detailHypertension and the arterial wall
Rorive, Georges ULg; Carlier, P.; Foidart, Jean-Michel ULg et al

in Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique (1981), 136(4), 237-53

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailHypertension and the kidney
Krzesinski, Jean-Marie ULg; Cohen, Eric P.

in Acta Clinica Belgica (2006), 62(1, Jan-Feb), 5-14

The kidney could be the cause of essential hypertension which can also cause renal disease. High blood pressure is also very common in chronic kidney disease, and is moreover a well-known risk factor for ... [more ▼]

The kidney could be the cause of essential hypertension which can also cause renal disease. High blood pressure is also very common in chronic kidney disease, and is moreover a well-known risk factor for a faster progression of kidney failure. Hypertension and kidneys are thus closely linked. Hypertension must be aggressively treated in patients suffering from chronic kidney disease, with a blood pressure goal of less than 130/80 mmHg, even lower than 125/75 mmHg when proteinuria is over 1g/day, using optimal and effective antihypertensive drugs. Among them, the blockers of the renin-angiotensin axis offer nephroprotective but also cardioprotective properties beyond their effect on blood pressure. [less ▲]

Detailed reference viewed: 27 (4 ULg)
See detailHypertension artérielle : nouvelles directives de prise en charge.
Krzesinski, Jean-Marie ULg

Conference (2004, March 11)

Detailed reference viewed: 7 (0 ULg)
See detailL'hypertension artérielle chez le diabétique
Krzesinski, Jean-Marie ULg

Conference (2002, May 16)

Detailed reference viewed: 12 (0 ULg)
Full Text
Peer Reviewed
See detailL'hypertension artérielle du sujet diabétique
Krzesinski, Jean-Marie ULg; Scheen, André ULg; Rorive, Georges ULg

in Médecine et Hygiène (1985), 43

Dans cette revue portant sur l'association diabète et hypertension artérielle, deux facteurs de risque pour le système cardiovasculaire, nous avons voulu insister sur la nécessité impérieuse de corriger ... [more ▼]

Dans cette revue portant sur l'association diabète et hypertension artérielle, deux facteurs de risque pour le système cardiovasculaire, nous avons voulu insister sur la nécessité impérieuse de corriger toute élévation tensionnelle chez un sujet diabétique. Ce but doit cependaat tenir compte des effets métaboliques potentiellement néfastes des médicaments mis à notre disposition. Le choix thérapeutique doit être l'aboutissement d'une réflexion portant sur le type d'hypertension, et donc sur le mécanisme physiopathologique probable de l'élévation de pression artérielle, et sur les effets secondaires possibles des substances antihypertensives. Une règle de conduite générale est proposée, à adapter cependant à chaque situation. Quel que soit le médicament choisi, le traitement de cette association hypertension artérielle-diabète fait la part belle aux mesures diététiques et à l'hygiène de vie. [less ▲]

Detailed reference viewed: 23 (0 ULg)
Full Text
Peer Reviewed
See detailL'hypertension artérielle essentielle peut-elle être prevenue?
Krzesinski, Jean-Marie ULg; Saint-Remy, Annie ULg

in Revue Médicale de Liège (2003), 58(4), 198-205

Prevalence of arterial hypertension is growing, in particular due to population ageing. Hypertension is a major risk factor for cardiovascular morbidity and mortality. Prevention is conceivable on a ... [more ▼]

Prevalence of arterial hypertension is growing, in particular due to population ageing. Hypertension is a major risk factor for cardiovascular morbidity and mortality. Prevention is conceivable on a theoretical basis by reduction or, if possible, prevention of excess weight, diet modifications, increased physical activity among other means. To be efficient, prevention should include an early detection of patients at risk and a long term assessment of efficacy requiring many efforts from both patients and physicians. [less ▲]

Detailed reference viewed: 128 (5 ULg)
See detailHypertension artérielle et accident vasculaire cérébral
Krzesinski, Jean-Marie ULg

Conference (2002, April 18)

Detailed reference viewed: 25 (14 ULg)
See detailHypertension artérielle et accident vasculaire cérébral
Krzesinski, Jean-Marie ULg

Conference (2001, November 15)

Detailed reference viewed: 17 (4 ULg)
See detailHypertension artérielle et alimentation
Krzesinski, Jean-Marie ULg

Conference (2008, December 02)

Detailed reference viewed: 12 (5 ULg)
Full Text
Peer Reviewed
See detailHypertension artérielle et antagonistes du récepteur de l'angiotensine II
Krzesinski, Jean-Marie ULg; Turatzinse, L.; Rorive, Georges ULg

in Médecine et Hygiène (1996), 2127

Dans l'hypertension artérielle et la décompensation cardiaque, les inhibiteurs de l'enzyme de conversion constituent un outil thérapeutique important mais, parfois, au prix de certains effets secondaires ... [more ▼]

Dans l'hypertension artérielle et la décompensation cardiaque, les inhibiteurs de l'enzyme de conversion constituent un outil thérapeutique important mais, parfois, au prix de certains effets secondaires (par exemple, la toux). De nouvelles perspectives de contrôle du système rénine angiotensine-aldostérone se profilent à l'horizon avec l'avènement des antagonistes des récepteurs de l'angiotensine Il. Le losartan est lepremier agent de cette famille, de nature non peptidique et actif par voie orale. Sa longue durée d'action permet une seule administration par jour. Cet agent bloque tous les effets connus de l'angiotensine II par une action au niveau des récepteurs appelés AT1. Au vu des premiers résultats publiés, il constitue un concurrent des inhibiteurs de l'enzyme de conversion dans l'hypertension et la décompensation cardiaque. [less ▲]

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailHypertension artérielle et artériopathie
Krzesinski, Jean-Marie ULg

in Revue Médicale de Liège (2002), 57(6), 370-374

High blood pressure as other factors of atherosclerosis is a well-known risk factor for development of peripheral arterial disease. A patient characterized by an isolated systolic hypertension and a low ... [more ▼]

High blood pressure as other factors of atherosclerosis is a well-known risk factor for development of peripheral arterial disease. A patient characterized by an isolated systolic hypertension and a low ankle/arm systolic blood pressure ratio very often presents coronary heart disease. Practising exercise (such as walking), stoping smoking and following an adapted diet are recommended. Hypertension treatment must be considered as a secondary prevention approach with a blood pressure normalisation as a target. All the different classes of antihypertensive drugs can be used, but with a marked preference for angiotensin converting enzyme (with caution for the renal artery stenosis risk) and for betablockers to improve the potential coronary heart disease (care is needed in the presence of severe peripheral arterial disease). [less ▲]

Detailed reference viewed: 109 (2 ULg)
Full Text
See detailHypertension artérielle et artériopathie
Krzesinski, Jean-Marie ULg

in Medi-Sphere (2002)

Detailed reference viewed: 8 (1 ULg)
Full Text
Peer Reviewed
See detailHypertension artérielle et cerveau
Milicevic, Martina; Krzesinski, Jean-Marie ULg

in Revue Médicale de Liège (2008), 63(5-6), 269-279

The relationships between the brain and arterial hypertension are strong. The brain, through the hypothalamus, can quickly adapt the blood pressure level to maintain the cerebral blood flow. An acute ... [more ▼]

The relationships between the brain and arterial hypertension are strong. The brain, through the hypothalamus, can quickly adapt the blood pressure level to maintain the cerebral blood flow. An acute increase in blood pressure, if it overtakes the autoregulatory capacities, needs an urgent intervention to decrease neurological problems such as encephalopathy. In chronic situations, arterial hypertension is a frequent cause of stroke, either ischemic or hemorragic, both in patients free and those who have already suffered from brain damage. Hypertension is also an actor in the genesis of vascular, but also Alzheimer dementia. A strict control of blood pressure (but also in other atherosclerotic risk factors) into the normal range is needed to protect the brain, and this is more important than the choice of a particular class of antihypertensive agents, except the betablockers. The risk starts from the normal values of blood pressure. [less ▲]

Detailed reference viewed: 186 (6 ULg)
See detailHypertension artérielle et diabète : comment gérer?
Krzesinski, Jean-Marie ULg

Conference (2004, February 19)

Detailed reference viewed: 8 (0 ULg)
Peer Reviewed
See detailHypertension arterielle et diabete de type 2.
Scheen, André ULg; Estrella, F.; Weekers, Laurent ULg

in Revue Médicale de Liège (1999), 54(10), 789-95

Diabetes mellitus is frequently associated with arterial hypertension and the combination of both entities markedly increases the vascular risk. In type 2 diabetes, hypertension appears very early ... [more ▼]

Diabetes mellitus is frequently associated with arterial hypertension and the combination of both entities markedly increases the vascular risk. In type 2 diabetes, hypertension appears very early, especially in the presence of obesity, is part of the insulin resistance syndrome, and contributes to high cardiovascular morbidity and mortality rates in this population. Appropriate regulation of blood pressure is crucial in order to reduce not only microangiopathy (nephropathy and retinopathy) but also macroangiopathy (coronary heart disease and stroke) in hypertensive type 2 diabetic patients. Target blood pressure values have been decreased in recent years and should be < 130/85 mmHg, and may be even lower according to recent data. The optimal modalities of pharmacological treatment remain controversial, but obviously several medications are required to reach such objectives in most hypertensive patients with type 2 diabetes. [less ▲]

Detailed reference viewed: 89 (0 ULg)
See detailHypertension artérielle et facteurs de risque
Krzesinski, Jean-Marie ULg

Conference (2004, January 14)

Detailed reference viewed: 11 (1 ULg)
See detailHypertension artérielle et néphropathie diabétique
Krzesinski, Jean-Marie ULg

Conference (2003, November 26)

Detailed reference viewed: 5 (0 ULg)
See detailHypertension artérielle et organes-cibles
Krzesinski, Jean-Marie ULg

Conference (2000, September 21)

Detailed reference viewed: 4 (0 ULg)